MedPath

Investigating the effect of implementing Levantal's self-regulation model on sexual function and satisfaction of women with diabetes in Qazvin city.

Not Applicable
Recruiting
Conditions
Investigating the effect of implementing Levantal's self-regulation model on sexual function and satisfaction of women with diabetes in Qazvin city.
Registration Number
IRCT20221114056495N1
Lead Sponsor
Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
90
Inclusion Criteria

Willingness to participate in the study
Age 15-49 years
Living in Qazvin province
At the time of study, be married and have sex
Minimum literacy
Ability to verbally communicate and answer questionnaire questions
Having type 1 or type 2 diabetes according to expert opinion and laboratory factors (recorded in the medical record)
not pregnant
At least 6 months have passed since the diagnosis of diabetes

Exclusion Criteria

Any physical illness with a doctor's approval in the person or partner that affects their sexual function or sexual satisfaction
Taking any type of medicine that (according to the patient) is effective on the patient's sexual function.
Participation in other sexual education or counseling sessions during the last month or at the beginning of the study
The existence of marital problems that affect people's sexual relations.
Patients with severe psychiatric disorders that require drug therapy (clinical and semi-clinical disorders)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sexual performance and sexual satisfaction. Timepoint: Before the start of the intervention, after that one month, two months and three months after the intervention. Method of measurement: Demographic and Fertility Questionnaire, Sexual Function Questionnaire (FSFI), Sexual Satisfaction Questionnaire (SSS-W), Disease Perception Questionnaire (IPQ-R) and Diabetes Severity Index (DCSI).
Secondary Outcome Measures
NameTimeMethod
Determining and comparing the level of understanding of the disease in women with diabetes in the control and test groups before and after the intervention. Timepoint: Before the intervention, one month, two months and three months after the intervention. Method of measurement: Illness perception will be measured with the Illness Perception Questionnaire (IPQ-R).
© Copyright 2025. All Rights Reserved by MedPath